Skip to main content
TipRanks
Go Ultimate75% OFF
Atavistik Bio logo

Atavistik Bio: Valuation, Funding & Investors

Cambridge, MA 02139, UShttps://atavistikbio.com/Precision Medicine

Atavistik Bio is a clinical-stage biotechnology company focused on discovering and developing precision allosteric small molecule therapeutics. The company leverages its proprietary AMPS™ platform to advance oral allosteric inhibitors targeting AKT1 for Hereditary Hemorrhagic Telangiectasia (HHT) and JAK2 V617F mutant-selective inhibitors for myeloproliferative neoplasms (MPNs).

Leadership & Board

Current Number of Employees
39
Current LinkedIn Followers
4,948

Latest Estimated Valuation

Total Amount Raised
$120M
Total Funding Rounds
1
Latest Funding Amount
$120M
Latest Funding Round
Series B

Company Momentum

Positive
Articles Published on TipRanks1
LinkedIn Trend+0.43% followers
Workforce Trend+0.0% employees

Atavistik Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

Atavistik Bio had 39 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.

39Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Atavistik Bio had 4,948 followers as of November 9, 2026. The number of followers increased by 21 (0.43%) week-over-week.

4,948Latest Followers Count
21(0.43%)Week-Over-Week Change
02,0004,0006,0008,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Dec 18, 2025Series B$120.00M―

Investors

Investor NameFunding Round
Lux CapitalSeries B
Nextech InvestSeries B
The Column GroupSeries B
Regeneron VenturesSeries B

Similar Companies

A snapshot of private companies similar to Atavistik Bio, helping you discover and navigate related company profiles.

Related News and Analysis